Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ezetimibe on Oxidized LDL in CAD
NCT01008345Phase 4Completed
- Sponsor
- Hôtel-Dieu de France
- Start
- Sep 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in coronary artery disease (CAD), sponsored by Hôtel-Dieu de France. Started Sep 2008; status: completed.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01008345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008345.